-
TRENDS AND DRIVERS FOR IN CANCER DRUGS FUND USE IN NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:16 PM -
THE EVOLVING TREATMENT LANDSCAPE OF MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA: APPROVED THERAPIES AND AN EXPANDING LATE-STAGE PIPELINE
Aug 11, 2026, 17:16 PM -
TREATMENT PATTERNS AND DISEASE BURDEN IN CHINESE PATIENTS WITH WHO GRADE 2 ASTROCYTOMA AND OLIGODENDROGLIOMA: A CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
EARLY HEALTH ECONOMIC MODELING TO INFORM INTERVENTION AND TRIAL DESIGN OF COMPLEX PUBLIC HEALTH INTERVENTIONS: A CASE STUDY OF A COMMUNITY PHARMACIST LED HYPERTENSION INTERVENTION IN BANGLADESH AND PAKISTAN
Aug 11, 2026, 17:16 PM -
WHEN IS EXISTING PATIENT PREFERENCE INFORMATION FIT-FOR-REUSE? RECOMMENDATIONS FROM AN EDELPHI STUDY
Aug 11, 2026, 17:16 PM -
MACHINE LEARNING PREDICTION OF NON-INVASIVE VENTILATION FAILURE IN COPD: A TRIPOD-ALIGNED REAL-WORLD ANALYSIS
Aug 11, 2026, 17:16 PM -
REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS FOR CELL AND GENE THERAPIES IN EUROPE
Aug 11, 2026, 17:16 PM -
MODELING THE POTENTIAL PUBLIC HEALTH IMPACT OF INTRODUCING ONE-DOSE BOOSTER MENINGOCOCCAL B VACCINATION (4CMENB) FOR ADOLESCENTS IN ENGLAND, SPAIN AND ITALY
Aug 11, 2026, 17:16 PM -
A COST EFFECTIVENESS ANALYSIS OF NGS-BASED PANEL FOR BREAST CANCER PATIENTS IN EGYPT
Aug 11, 2026, 17:16 PM -
THE VALUE OF INVESTING IN HIV CARE IN THE NETHERLANDS: SOCIETAL GAIN AND REMAINING CHALLENGES
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGICAL, CLINICAL, ECONOMIC, AND HUMANISTIC BURDEN OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE UNITED ARAB EMIRATES: A MARKOV STATE-TRANSITION MODELING STUDY
Aug 11, 2026, 17:16 PM -
INTEGRATING DISCRETE CHOICE EXPERIMENT EVIDENCE INTO HEALTH ECONOMIC EVALUATIONS: A FRAMEWORK FOR PATIENT-CENTERED VALUE ASSESSMENT
Aug 11, 2026, 17:16 PM -
CONTENT VALIDITY AND PSYCHOMETRIC EVALUATION OF THE URTICARIA SYMPTOM DAILY DIARY (USDD) IN CHRONIC INDUCIBLE URTICARIA
Aug 11, 2026, 17:16 PM -
FROM REAL-WORLD DATA (RWD) TO IN-SILICO DESIGN: AN INTEGRATED APPROACH TO OPTIMISE STUDY DESIGN AND DECISION MAKING
Aug 11, 2026, 17:16 PM -
SYMPTOM BURDEN IN BRONCHIECTASIS: RESULTS OF A TARGETED LITERATURE REVIEW AND PATIENT FOCUS GROUPS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF FOUR FIRST-LINE ANTI-VIRAL TREATMENTS FOR HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CHINA
Aug 11, 2026, 17:16 PM -
WEIGHTING FOR GODOT: WHEN MAICS MOVE THE ESTIMATE BUT NOT THE UNCERTAINTY
Aug 11, 2026, 17:16 PM -
UPTAKE OF THE NICE SEVERITY MODIFIER: WHAT PROPORTION OF APPLICATIONS QUALIFY?
Aug 11, 2026, 17:16 PM -
ESTIMATING THE INPATIENT ECONOMIC BURDEN OF OBESITY IN GREECE: A NATIONWIDE POPULATION ATTRIBUTABLE FRACTION ANALYSIS USING REAL-WORLD HOSPITAL DATA
Aug 11, 2026, 17:16 PM -
THE HIDDEN COST OF ACCESS: INTEGRATING HTA, EVIDENCE GENERATION, AND MANAGED ENTRY AGREEMENT REQUIREMENTS INTO COST-BASED PRICING MODELS FOR CELL AND GENE THERAPIES
Aug 11, 2026, 17:16 PM
